Yao, Z.-K., Wardell, S., Spasojevic, I., Norris, J., Katzenellenbogen, J., McDonnell, D., & Josan, J. (2017). Discovery of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (Vol. 254). Washington, DC: AMER CHEMICAL SOC.

Yao, Zhong-Ke, Suzanne Wardell, Ivan Spasojevic, John Norris, John Katzenellenbogen, Donald McDonnell, and Jatinder Josan. “Discovery of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer.” In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, Vol. 254. AMER CHEMICAL SOC, 2017.

Yao Z-K, Wardell S, Spasojevic I, Norris J, Katzenellenbogen J, McDonnell D, et al. Discovery of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. AMER CHEMICAL SOC; 2017.

Yao, Zhong-Ke, et al. “Discovery of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer.” ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, vol. 254, AMER CHEMICAL SOC, 2017.

Yao Z-K, Wardell S, Spasojevic I, Norris J, Katzenellenbogen J, McDonnell D, Josan J. Discovery of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. AMER CHEMICAL SOC; 2017.